Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
Conditions: Asthma; Rhinitis AllergicIntervention: Drug: MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified May 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials